Optimisation and Validation of an Induced Membrane Technique Model to Assess Bone Regeneration in Rats

Area of Science:

• Orthopedics
• Biomaterials Science
• Regenerative Medicine

Background:

• Induced membrane (IM) technique shows promise for bone regeneration but requires optimized preclinical models.
• Few studies have validated IM models for assessing bone regeneration achievement, particularly with biomaterials.
• Optimizing IM preclinical models can simplify surgical procedures and improve clinical outcomes in bone grafting.

Purpose of the Study:

• To optimize and validate an in vivo induced membrane (IM) preclinical model in rats for bone regeneration.
• To evaluate the effectiveness of biomaterials as bone graft substitutes within this validated model.
• To establish a critical bone defect size and surgical parameters for reliable biomaterial assessment.

Main Methods:

• Developed an in vivo IM model in Lewis rats using a 4-mm critical bone defect in the femur, stabilized with osteosynthesis plates.
• Optimized osteotomy methods (piezotomy vs. others) and osteosynthesis plate/screw dimensions for model efficiency.
• Evaluated bone regeneration histologically and radiologically at 24 weeks, comparing negative controls, positive controls (syngeneic bone graft), and biomaterial (GlassBone Noraker) groups.

Main Results:

• Piezotomy and 1-mm thick plates with 2.0-mm diameter screws were identified as optimal surgical parameters.
• Complete bone defect ossification was achieved only in the group receiving both surgical stages and a syngeneic bone graft.
• The 4-mm defect confirmed critical nature (no significant ossification without graft), and IM with GlassBone alone resulted in incomplete regeneration.

Conclusions:

• A two-stage bone regeneration model in rats requires piezotome osteotomy and a sufficiently stiff osteosynthesis plate.
• The 4-mm critical bone defect is validated as suitable for evaluating biomaterials using the induced membrane technique.
• This optimized model provides a reliable platform for assessing the efficacy of bone graft substitutes.